Heart Disease Clinical Trials in Salt Lake City

Showing 61-80 of 197 trials

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

NCT04766892

This is a Phase 2a proof-of-concept study to assess safety, tolerability, and preliminary efficacy of mavacamten treatment on biomarker levels in participants with heart failure with preserved ejection fraction (HFpEF) and elevation of NT-proBNP with or without elevation of cTnT. Data from this study will inform future study designs of mavacamten in patients with HFpEF.

Heart Failure With Preserved Ejection Fraction

Bristol-Myers Squibb30 participantsStarted Mar 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +18 more locations

ACTIVE_NOT_RECRUITINGNA< 1 mile

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

NCT03533517

This is a non-randomized, prospective, multi-center Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF).

Heart FailureCardiomyopathy, Dilated

Ancora Heart, Inc.22 participantsStarted Aug 2018

San Francisco, California, United States • Atlanta, Georgia, United States • Louisville, Kentucky, United States +15 more locations

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

Heart Disease Trials in Other Cities

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Benefits of µCor in Ambulatory Decompensated Heart Failure

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

REmodeling the Left Ventricle With Atrial Modulated Pacing

Benefits of Microcor in Ambulatory Decompensated Heart Failure

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

ELUCIDATE FFRct Study

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon

Effect of Fetal Aortic Valvuloplasty on Outcomes

Communication During Hospitalization About Resuscitation Trial

Other Conditions in Salt Lake City